Physicians' brain scans indicate doctors can feel their patients' pain—and their relief
January 29, 2013 in Psychology & Psychiatry
A patient's relationship with his or her doctor has long been considered an important component of healing. Now, in a novel investigation in which physicians underwent brain scans while they believed they were actually treating patients, researchers have provided the first scientific evidence indicating that doctors truly can feel their patients' pain – and can also experience their relief following treatment.
Led by researchers at Massachusetts General Hospital (MGH) and the Program in Placebo Studies and Therapeutic Encounter (PiPS) at Beth Israel Deaconess Medical Center/Harvard Medical School, the new findings, which appear on-line today in Molecular Psychiatry, help to illuminate one of the more intangible aspects of health care – the doctor/patient relationship.
"Our findings showed that the same brain regions that have previously been shown to be activated when patients receive placebo therapies are similarly activated in the brains of doctors when they administer what they think are effective treatments," explains first author Karin Jensen, PhD, an investigator in the Department of Psychiatry and Martinos Center for Biological Imaging at MGH and member of the PiPS. Notably, she adds, the findings also showed that the physicians who reported greater ability to take things from the patients' perspective, that is, to empathize with patients' feelings, experienced higher satisfaction during patients' treatments, as reflected in the brain scans.
"By demonstrating that caring for patients involves a complex set of brain events, including deep understanding of the patient's facial and body expressions, possibly in combination with the physician's own expectations of relief and feelings of reward, we have been able to elucidate the neurobiology underlying caregiving," adds senior author Ted Kaptchuk, director of the PiPS and Associate Professor of Medicine at Harvard Medical School. "Our findings provide early evidence of the importance of interacting brain networks between patients and caregivers and acknowledge the doctor/patient relationship as a valued component of health care, alongside medications and procedures."
Previous investigations have demonstrated that a brain region associated with pain relief (right ventrolateral prefrontal cortex, VLPFC) and a region associated with reward (rostral anterior cingulate cortex, rACC) are activated when patients experience the placebo effect, which occurs when patients show improvement from treatments that contain no active ingredients. The placebo effect accounts for significant portions of clinical outcomes in many illnesses—including pain, depression and anxiety.
Although behavioral research has suggested that physicians' expectations influence patients' clinical outcomes and help determine patients' placebo responses, until now little effort has been directed to understanding the biology underlying the physician component of the clinical relationship. Jensen and her colleagues hypothesized that the same brain regions that are activated during patients' placebo responses – the VLPFC and rACC—would similarly be activated in the brains of physicians as they treated patients. They also hypothesized that a physician's perspective-taking skills would influence the outcomes.
To test these hypotheses, the scientists developed a unique equipment arrangement that would enable them to conduct functional magnetic resonance imaging (fMRI) of the physicians' brains while the doctors had face-to-face interactions with patients, including observing patients as they underwent pain treatments.
The experiment included 18 physicians (all of whom had received their medical degree within the last 10 years and represented nine separate medical specialties). Two 25-year-old females played the role of "patients" and followed a rehearsed script. The experiment called for the participating physicians to administer pain relief with what they thought was a pain-relieving electronic device, but which was actually a non-active "sham" device.
To ensure that the physicians believed that the sham device really worked, the investigators first administered a dose of "heat pain" to the physicians' forearms to gauge pain threshold and then "treated" them with the fake machine. During the treatments, the investigators reduced the heat stimulation, to demonstrate to the participants that the therapy worked. The physicians underwent fMRI scans while they experienced the painful heat stimulation so that investigators could see exactly which brain regions were activated during first-person perception of pain.
In the second portion of the experiment,each physician was introduced to a patient and asked to perform a standardized clinical examination, which was conducted in a typical exam room for approximately 20 minutes. (The clinical exam was performed in order to establish a realistic rapport between the physician and patient before fMRI scanning took place, and was comparable to a standard U.S. doctor's appointment.) At this point the physician also answered a questionnaire, the Interpersonal Reactivity Index, used to measure the participant's self-reported perspective-taking skills.
During the third step, says Jensen, the physician and patient were led into the scanner room. "The physician went inside the scanner and was equipped with a remote control that could activate the 'analgesic device' when prompted," she explains. Mirrors inside the scanner enabled physicians to maintain eye contact with the patient, who was seated on a chair next to the scanner's bed and hooked up to both the thermal pain stimulator and the pain-relieving device.
Then, in a randomized order, physicians were instructed to either treat a patient's pain or to press a control button that provided no relief. When physicians were told not to activate pain relief, the "patient" exhibited a painful facial expression while the physicians watched. When the physicians were instructed to treat the patients' pain, they could see that the subjects' faces were neutral and relaxed, the result of pain relief. During these doctor-patient interactions, fMRI scans measured the doctors' brain activations.
Following the scanning session, the physicians were removed from the scanner and told exactly how the experiment had been performed, says Jensen. "If the physician did not agree with the deceptive component of the study, they were given the opportunity to withdraw their data. No one did this."
As predicted, the authors found that while treating patients, the physicians activated the right VLPFC region of the brain, a region previously implicated in the placebo response. Furthermore, Jensen adds, the physicians' ability to take the patients' viewpoints correlated to brain activations and subjective ratings; physicians who reported high perspective-taking skills were more likely to show activation in the rACC brain region, which is associated with reward.
"We already know that the physician-patient relationship provides solace and can even relieve many symptoms," adds Kaptchuk. "Now, for the first time, we've shown that caring for patients encompasses a unique neurobiology in physicians. Our ultimate goal is to transform the 'art of medicine' into the 'science of care,' and this research is an important first step in this process as we continue investigations to find out how patient-clinician interactions can lead to measurable clinical outcomes in patients."
Journal reference:
Molecular Psychiatry
Provided by
Beth Israel Deaconess Medical Center
-
Placebo response, pain experience occur at nonconscious level: study
Sep 10, 2012 |
not rated yet |
0
-
A closer look at the placebo effect
Jul 13, 2011 |
not rated yet |
0
-
Referral decisions differ between primary care physicians and specialists
Sep 19, 2011 |
not rated yet |
0
-
Doctor-patient relationship influences patient engagement
Nov 29, 2011 |
not rated yet |
0
-
New imaging technique captures brain activity in patients with chronic low back pain
Jul 27, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
How can there be a term called "intestinal metaplasia" of stomach
19 hours ago
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
Weather worries can threaten a child's mental health
(HealthDay)—The monstrous tornado that devastated Moore, Okla., on Monday, killing dozens of adults and children, is a stunning example of violent weather that can affect a child's mental well-being.
Psychology & Psychiatry
10 hours ago |
not rated yet |
0
Teens exposed to schoolmate's death by suicide much more likely to consider or attempt suicide
Youth who had a schoolmate die by suicide are significantly more likely to consider or attempt suicide, according to a study in published in CMAJ (Canadian Medical Association Journal). This effect can last 2 years or mo ...
Psychology & Psychiatry
14 hours ago |
not rated yet |
0
Genetic predictors of postpartum depression uncovered
Johns Hopkins researchers say they have discovered specific chemical alterations in two genes that, when present during pregnancy, reliably predict whether a woman will develop postpartum depression.
Psychology & Psychiatry
22 hours ago |
not rated yet |
0
|
Mediterranean diet seems to boost ageing brain power
A Mediterranean diet with added extra virgin olive oil or mixed nuts seems to improve the brain power of older people better than advising them to follow a low-fat diet, indicates research published online in the Journal of ...
Psychology & Psychiatry
May 20, 2013 |
3.5 / 5 (2) |
2
The incidence of eating disorders is increasing in the UK
More people are being diagnosed with eating disorders every year and the most common type is not either of the two most well known—bulimia or anorexia—but eating disorders not otherwise specified (eating disorders that ...
Psychology & Psychiatry
May 20, 2013 |
not rated yet |
0
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.